|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/385 | (2006.01) |
| A61K 39/092 | (2013.01) | ||
| A61K 47/50 | (2017.01) | ||
| A61K2039/6037 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 47/6415 | (2017.08) | ||
| A61K 47/646 | (2017.08) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Number of the document | 3443983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18191446.6 |
| Date of filing the European patent application | 2015-02-06 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461939845 P | 2014-02-14 | US |
| (72) |
GU, Jianxin , US
KAINTHAN, Rajesh Kumar , US
KIM, Jin-Hwan , US
PRASAD, Avvari Krishna , US
YANG, Yu-ying , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMMUNOGENIC GLYCOPROTEIN CONJUGATES |
| IMMUNOGENIC GLYCOPROTEIN CONJUGATES |